Log In
BCIQ
Print this Print this
 

glucagon injection (G-Pen)

  Manage Alerts
Collapse Summary General Information
Company Xeris Pharmaceuticals Inc.
DescriptionStable liquid glucagon
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat severe hypoglycemia in diabetics
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today